Intravenous Vitamin C Linked to Lower Mortality in Trauma Patients

A systematic review published this week suggests that high‑dose vitamin C administration may reduce mortality among patients who have suffered severe traumatic injuries. The analysis, which pooled data from 12 randomized controlled trials involving more than 3,000 participants, found that those who received intravenous vitamin C within the first 24 hours after injury had a 12 % lower risk of death compared with standard care alone. The authors noted that the effect was most pronounced in patients with multiple organ failure and in those who received treatment within the first six hours.

The review highlights the growing interest in antioxidants as adjunctive therapy in trauma care. Vitamin C, a potent free‑radical scavenger, is thought to mitigate oxidative stress, stabilize endothelial function, and support immune responses that are often compromised after major injury. While the included studies varied in dosage and timing, the overall evidence points to a consistent trend toward improved survival. Nonetheless, the authors cautioned that the trials were heterogeneous in design and that larger, multicenter studies are needed to confirm the benefit and establish optimal dosing regimens.

If future research confirms these findings, intravenous vitamin C could become a low‑cost, easily administered intervention to improve outcomes for trauma patients worldwide. Until then, clinicians should weigh the current evidence against individual patient factors and existing guidelines when considering antioxidant therapy in the acute setting.